在阿尔茨海默氏症研究中缺少数据归算的机器学习:预测中间叶动态灵活性
Soodeh Moallemian1, Abolfazl Saghafi2, Rutvik Deshpande1
1Center for Molecular & Behavioral Neuroscience, Rutgers, The State University of New Jersey, Newark, United States.
Cognitive neurodynamics
|February 13, 2026
概括
准确的归算方法对于分析缺失值的神经成像数据至关重要. 像GAIN和MissForest这样的先进技术显著改善了老年大脑中中部叶灵活性的预测.
科学领域:
- 神经科学是一个神经科学.
- 生物统计学 生物统计学
- 老年学是一门学科.
背景情况:
- 阿尔茨海默病 (AD) 的病理学先于临床症状.
- 中间叶 (MTL) 动态灵活性可以作为早期的AD生物标志物.
- 神经成像研究经常面临大量数据缺失.
研究的目的:
- 评估估算策略,以估计老年人的MTL动态灵活性.
- 在各种归算方法和回归模型中比较预测准确度.
- 为了确定高缺失的神经成像数据的最佳归算技术.
主要方法:
- 利用了来自656名老年人的数据.
- 与五种归算策略 (MICE,GAIN,MissForest,MIWAE,ReMasker) 的完整案例分析进行了比较.
- 使用重复的5倍交叉验证与八种回归模型评估预测准确性.
主要成果:
- 完整病例分析显示性能有限.
- 所有的归算方法都比完整案例分析提高了准确性.
- 森林小姐和GAIN,特别是用集合树模型,实现了最低的预测误差和最高的一致性收益.
结论:
- 强大的归算对于在缺少数据的神经成像研究中最大限度地提高数据效用至关重要.
- 先进的归算技术,特别是GAIN和MissForest,结合合集树模型,提高了MTL动态灵活性的预测可靠性.
- 这些发现支持在早期的AD生物标志物研究中使用复杂的归算方法.
相关概念视频
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...